Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Cohort Study on the Age-related Macular Degeneration: Incidence and Research for Predisposing Factors

NCT01918553
completed

Effects of Smoking and Vitamin D3 on the Levels of Human Cathelicidin Peptide LL-37

NCT03923218
completed

Added Value of Speckle Tracking in the Evaluation of Patients With Sickle Cell Disease

NCT02394431

Clinical Trials (3)

Showing 3 of 3 trials
NCT01918553Not Applicable

Cohort Study on the Age-related Macular Degeneration: Incidence and Research for Predisposing Factors

Completed
NCT03923218

Effects of Smoking and Vitamin D3 on the Levels of Human Cathelicidin Peptide LL-37

Completed
NCT02394431

Added Value of Speckle Tracking in the Evaluation of Patients With Sickle Cell Disease

Completed

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3